“…The 88.1% device success rate of this study was within the range of the 87–94% device success rate [3,9,18,19,20,21], but the 92.9% was slightly lower than the 96–100% procedural success rate [2,3,19,20,21,22,23] reported for the same device in 5-, 6- or 7-Fr punctures. The 7.1% major vascular complication rate attributable to StarClose in this study was higher than previously reported 0–4.1% [2,3,4,5,6,9,18,19,20,21,22,23,24], but the minor 11.9% complication rate was within the range of 2.1–27%, even though the device was used for closing larger puncture holes.…”